Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FSEAQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,626
Award facts
- Contract value 100% obligated
- $7,625.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp received a delivery order from the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections, with a contract ceiling value of $7,625.80. The order is structured as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and represents a non-set-aside competitive award. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications and medical supplies to support military healthcare programs. Zepbound, a GLP-1 receptor agonist indicated for weight management, represents one of the specialized pharmaceutical products provided through this contract vehicle to support Defense Health Agency and other federal healthcare systems. The competitive nature of the award and AmerisourceBergen's demonstrated capability across multiple therapeutic domains underscore the company's role as a critical pharmaceutical vendor for the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FSEAQ?
SPE2DB25FSEAQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FSEAQ worth?
The government has obligated $7,626 on SPE2DB25FSEAQ.
Is contract SPE2DB25FSEAQ an order under another contract?
Yes. SPE2DB25FSEAQ is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSEAQ competed?
The extent of competition for SPE2DB25FSEAQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award